Subtypes of antipsychotics and suicidal behavior in bipolar disorder

Journal of Affective Disorders

Volumn 143, Issue 1-3, 2012, Pages 27-33

  Koek, Ralph J ^a,b   Yerevanian, Boghos I ^b   Mintz, Jim ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antipsychotics; Attempted suicide; Bipolar disorder; Carbamazepine; Divalproex; Lithium

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; VETERAN;

ADULT; AGED; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISPERIDONE; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED; VETERANS;

EID: 84869506021     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.05.053     Document Type: Article

References (44)

1. A.C. Altamura, R. Bassetti, S. Bignotti, R. Pioli, and E. Mundo Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study Schizophrenia Research 60 2003 47 55
2. A. Agresti Categorical Data Analysis 1990 John Wiley & Sons New York, NY pp. 189-196
3. R. Baldessarini, H. Henk, A. Sklar, J. Chang, and L. Leahy Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence Psychiatric Services 59 2008 1175 1183
4. Y. Barak, I. Mireki, H.Y. Knobler, Z. Natan, and D. Aizenberg Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period Psychopharmacology (Berl) 175 2004 215 219
5. M. Bauer, H.W. Pretorius, E.L. Constant, W.R. Earley, J. Szamosi, and M. Brecher Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study Journal of Clinical Psychiatry 70 2009 540 549
6. R.M. Berman, R.N. Marcus, R. Swanink, R.D. McQuade, W.H. Carson, P.K. Corey-Lisle, and A. Khan The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study Journal of Clinical Psychiatry 68 2007 843 853
7. D.J. Bond, W. Pratoomsri, and L.N. Yatham Depot antipsychotic medications in bipolar disorder: a review of the literature Acta Psychiatrica Scandinavica Supplementum 434 2007 3 16
8. J.R. Calabrese, P.E. Keck Jr., W. Macfadden, M. Minkwitz, T.A. Ketter, R.H. Weisler, A.J. Cutler, R. McCoy, E. Wilson, and J. Mullen A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression American Journal of Psychiatry 162 2005 1351 1360
9. K.R. Connolly, and M.E. Thase The clinical management of bipolar disorder: a review of evidence-based guidelines Primary Care Companion to CNS Disorders 13 4 2011 pii: PCC.10r01097. PMID: 22132354
10. C. Depp, V.D. Ojeda, W. Mastin, J. Unützer, and T.P. Gilmer Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004 Psychiatric Services 59 2008 1169 1174
11. S. Dittmann, N.C. Biedermann, H. Grunze, B. Hummel, L.O. Schärer, N. Kleindienst, A. Forsthoff, N. Matzner, S. Walser, and J. Walden The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres Neuropsychobiology 46 Suppl. 1 2002 2 9
12. J.F. Goldberg, M.H. Allen, D.A. Miklowitz, C.L. Bowden, C.J. Endick, C.A. Chessick, S.R. Wisniewski, S. Miyahara, K. Sagduyu, M.E. Thase, J.R. Calabrese, and G.S. Sachs Suicidal ideation and pharmacotherapy among STEP-BD patients Psychiatric Services 56 2005 1534 1540
13. M. Hamilton Development of a rating scale for primary depressive illness British Journal of Social and Clinical Psychology 6 1967 278 296
14. J. Haukka, J. Tiihonen, T. Härkänen, and J. Lönnqvist Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia Pharmacoepidemiology and Drug Safety 17 2008 686 696
15. J. Hennen, and R.J. Baldessarini Suicidal risk during treatment with clozapine: a meta-analysis Schizophrenia Research 73 2005 139 145
16. J.P. Houston, J. Ahl, A.L. Meyers, C.J. Kaiser, M. Tohen, and R.J. Baldessarini Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex Journal of Clinical Psychiatry 67 2006 1246 1252
17. M.A. Ilgen, E.K. Czyz, D.E. Welsh, J.E. Zeber, M.S. Bauer, and A.M. Kilbourne A collaborative therapeutic relationship and risk of suicidal ideation in patients with bipolar disorder Journal of Affective Disorders 115 2009 246 251
18. O.N. Karayal, S.D. Anway, E. Batzar, and D.G. Vandenburg Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone Journal of Clinical Psychiatry 72 2011 367 375
19. P.E. Keck Jr. Bipolar depression: a new role for SGA antipsychotics? Bipolar Disorders 7 Suppl. 4 2005 34 40
20. E. Lauterbach, W. Felber, B. Müller-Oerlinghausen, B. Ahrens, T. Bronisch, T. Meyer, B. Kilb, U. Lewitzka, B. Hawellek, A. Quante, K. Richter, A. Broocks, and F. Hohagen Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial Acta Psychiatrica Scandinavica 118 2008 469 479
21. S. Lewis, and J. Lieberman CATIE and CUtLASS: can we handle the truth? British Journal of Psychiatry 192 2008 161 163
22. J.A. Lieberman, G. Tollefson, M. Tohen, A.I. Green, R.E. Gur, R. Kahn, J. McEvoy, D. Perkins, T. Sharma, R. Zipursky, H. Wei, R.M. Hamer, and HGDH Study Group Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol American Journal of Psychiatry 160 2003 1396 1404
23. L.B. Marangell, E.B. Dennehy, S.R. Wisniewski, M.S. Bauer, S. Miyahara, M.H. Allen, M. Martinez, R.K. Al Jurdi, and M.E. Thase Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD Journal of Clinical Psychiatry 69 2008 916 922
24. R.N. Marcus, R.D. McQuade, W.H. Carson, D. Hennicken, M. Fava, J.S. Simon, M.H. Trivedi, M.E. Thase, and R.M. Berman The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study Journal of Clinical Psychopharmacology 28 2008 156 165
25. H.Y. Meltzer, L. Alphs, A.I. Green, A.C. Altamura, R. Anand, A. Bertoldi, M. Bourgeois, G. Chouinard, M.Z. Islam, J. Kane, R. Krishnan, J.P. Lindenmayer, S. Potkin, and International Suicide Prevention Trial Study Group Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Archives of General Psychiatry 60 2003 82 91 Erratum in: Arch. Gen. Psychiatry 2003 60,735
26. J. Modestin, J.D. Dal Pian, and P. Agarwalla Clozapine diminishes suicidal behavior: a retrospective evaluation of clinical records Journal of Clinical Psychiatry 66 2005 534 538
27. A.M. Nivoli, A. Murru, J.M. Goikolea, J.M. Crespo, J.M. Montes, A. González-Pinto, P. García-Portilla, J. Bobes, J. Sáiz-Ruiz, and E. Vieta New treatment guidelines for acute bipolar mania: a critical review Journal of Affective Disorders 2011
28. D. Novick, C. Reed, J.M. Haro, A. Gonzalez-Pinto, E. Perrin, J. Aguado, and M. Tohen Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice International Clinical Psychopharmacology 25 2010 257 263
29. J. Pillarella, A. Higashi, G.C. Alexander, and R. Conti Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009 Psychiatric Services 63 2012 83 86
30. R.M. Post, G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, P.E. Keck, S.L. McElroy, W.A. Nolen, R. Kupka, H. Grunze, J. Walden, and M. Rowe Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany International Clinical Psychopharmacology 26 2011 96 106
31. T. Pringsheim, D. Lam, D.S. Tano, and S.B. Patten The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009 Canadian Journal of Psychiatry 56 2011 630 634
32. A. Quante, S. Zeugmann, F. Regen, A. Engelhardt, and I.G. Anghelescu Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany Psychiatry Investigation 7 2010 155 162
33. H. Reeves, S. Batra, R.S. May, R. Zhang, D.C. Dahl, and X. Li Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study Journal of Clinical Psychiatry 69 2008 1228 1336
34. G. Remington Understanding antipsychotic atypicality: a clinical and pharmacological moving target Journal of Psychiatry & Neuroscience 28 2003 275 284
35. J. Sankaranarayanan, and S.E. Puumala Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors Clinical Therapy 29 2007 723 741
36. J. Tiihonen, K. Walhbeck, J. Lönnqvist, T. Klaukka, J.P. Ioannidis, J. Volavka, and J. Haukka Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study British Medical Journal 333 7561 2006 224 229
37. G.D. Tollefson, T.M. Sanger, Y. Lu, and M.E. Thieme Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol Archives of General Psychiatry 55 1998 250 258
38. M. Tohen, W. Greil, J.R. Calabrese, G.S. Sachs, L.N. Yatham, B.M. Oerlinghausen, A. Koukopoulos, G.B. Cassano, H. Grunze, R.W. Licht, L. Dell'Osso, A.R. Evans, R. Risser, R.W. Baker, H. Crane, M.R. Dossenbach, and C.L. Bowden Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial American Journal of Psychiatry 162 2005 1281 1290
39. M. Ulcickas Yood, G. Delorenze, C.P. Quesenberry Jr., A.L. Tsai, S. Phillips, V.J. Willey, S.J. Niemcryk, K. Wells, M.L. Skovron, M.J. Cziraky, W. Carson, and S.A. Oliveria Epidemiologic study of aripiprazole use and the incidence of suicide events Pharmacoepidemiology and Drug Safety 19 2010 1124 1130
40. E. Vieta, E. Nieto, A. Autet, A.R. Rosa, J.M. Goikolea, N. Cruz, and P. Bonet A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone World Journal of Biological Psychiatry 9 2008 219 224
41. A. Ward, K. Ishak, I. Proskorovsky, and J. Caro Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study Clinical Therapy 28 2006 1912 1921
42. M. Yang, J.C. Barner, K.A. Lawson, K.L. Rascati, J.P. Wilson, M.L. Crismon, J. Worchel, and C.A. Mascarenas Antipsychotic medication utilization trends among Texas veterans: 1997-2002 Annals of Pharmacotherapy 42 2008 1229 1238
43. B.I. Yerevanian, R.J. Koek, and J. Mintz Bipolar pharmacotherapy and suicidal behavior. Part 3: impact of antipsychotics Journal of Affective Disorders 103 2007 23 28
44. B.I. Yerevanian, R.J. Koek, and J. Mintz Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex and carbamazepine Journal of Affective Disorders 103 2007 5 11